Cargando…
Regulation of Platelet-Derived ADAM17: A Biomarker Approach for Breast Cancer?
Tumor progression and metastasis are critically dependent on the tumor microenvironment. A disintegrin and metalloproteinase 17 (ADAM17) is associated with shedding of several substrates involved in tumor progression and known to be expressed by platelets of healthy donors and patients with solid tu...
Autores principales: | Zhou, Yanjun, Heitmann, Jonas S., Kropp, Korbinian N., Hinterleitner, Martina, Koch, André, Hartkopf, Andreas D., Salih, Helmut R., Hinterleitner, Clemens, Maurer, Stefanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305148/ https://www.ncbi.nlm.nih.gov/pubmed/34208863 http://dx.doi.org/10.3390/diagnostics11071188 |
Ejemplares similares
-
Platelet-Expressed TNFRSF13B (TACI) Predicts Breast Cancer Progression
por: Hinterleitner, Clemens, et al.
Publicado: (2021) -
Platelet-expressed immune checkpoint regulator GITRL in breast cancer
por: Zhou, Yanjun, et al.
Publicado: (2021) -
Controversial Role of the Immune Checkpoint OX40L Expression on Platelets in Breast Cancer Progression
por: Rittig, Susanne M., et al.
Publicado: (2022) -
Modulation of Immune Responses by Platelet-Derived ADAM10
por: Maurer, Stefanie, et al.
Publicado: (2020) -
Platelets subvert antitumor efficacy of T cell-recruiting bispecific antibodies
por: Lutz, Martina Svenja, et al.
Publicado: (2022)